Publication de 12 numéros par an
ISSN Imprimer: 1521-9437
ISSN En ligne: 1940-4344
Indexed in
Suppressive Effect of Fruiting Bodies of Medicinal Mushrooms on Demyelination and Motor Dysfunction in a Cuprizone-Induced Multiple Sclerosis Mouse Model
RÉSUMÉ
Epidemiologic studies have shown a high prevalence of multiple sclerosis (MS) in Europe and North America, and a low prevalence in East Asia. Mushrooms contain various biological response modifiers (BRMs) and are widely used in traditional Chinese medicine in East Asian countries. To investigate whether mushrooms have potential beneficial effects on MS, we administered mushrooms to cuprizone (bis-cyclohexanone-oxalyldihydrazone, CPZ)-induced MS model mice. This model is used to study the processes of demyelination in the CNS. The CPZ-induced demyelination is involved in the apoptotic death of mature oligodendrocytes, neuroinflammation, and motor dysfunction. Mice were fed a powdered diet containing 5% each mushroom and CPZ diet for 5 weeks, which coincides with peak demyelination. We measured the body weight of the mice, evaluated their motor function using a rotarod, and quantified the myelin levels using Black-Gold II staining. Ganoderma lucidum and Hericium erinaceus treatments showed recovery from weight loss. Pleurotus eryngii, G. lucidum, and Flammulina velutipes treatments significantly improved CPZ-induced motor dysfunction. P. eryngii, G. lucidum, F. velutipes, and H. erinaceus treatments effectively suppressed CPZ-induced demyelination. The four medicinal mushrooms may be promising BRMs for prevention and alleviation of the symptoms of MS.
-
Lassmann H. Pathology and disease mechanisms in different stages of multiple sclerosis. J Neurol Sci. 2013;333(1-2):1.
-
Hauser SL, Cree BAC. Treatment of multiple sclerosis: A review. Am J Med. 2020;133(12):1380-90.e1382.
-
Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001;11(1):107-16.
-
Zhan J, Mann T, Joost S, Behrangi N, Frank M, Kipp M. The cuprizone model: Dos and do nots. Cells. 2020;9(4).
-
Maity P, Sen IK, Chakraborty I, Mondal S, Bar H, Bhanja SK, Mandal S, Maity GN. Biologically active polysaccharide from edible mushrooms: A review. Int J Biol Macromol. 2021;172:408-17.
-
Rai SN, Mishra D, Singh P, Vamanu E, Singh MP. Therapeutic applications of mushrooms and their biomolecules along with a glimpse of in silico approach in neurodegenerative diseases. Biomed Pharmacother. 2021;137:111377.
-
Lu J, He R, Sun P, Zhang F, Linhardt RJ, Zhang A. Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (lingzhi), a review. Int J Biol Macromol. 2020;150:765-74.
-
Thongbai B, Rapior S, Hyde KD, Wittstein K, Stadler M. Hericium erinaceus, an amazing medicinal mushroom. Mycol Progress. 2015;14(91).
-
Mori K, Obara Y, Hirota M, Azumi Y, Kinugasa S, Inatomi S, Nakahata N. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull. 2008;31(9):1727-32.
-
Wang Y, Zhang H. Advances in the extraction, purification, structural-property relationships and bioactive molecular mechanism of Flammulina velutipes polysaccharides: A review. Int J Biol Macromol. 2021;167:528-38.
-
Han EH, Hwang YP, Kim JH, Choi JG, Im JH, Yang JH, Lee HU, Chun HH, Chung YH, Jeong HY. Inhibitory effect of Pleurotus eryngii extracts on the activities of allergic mediators in antigen-stimulated mast cells. Food Chem Toxicol. 2011;49(6):1416-25.
-
Gao Z, Lai Q, Yang Q, Xu H, Liu W, Zhao F, Liu X, Zhang C, Zhang J, Jia L. The characteristic, antioxidative and multiple organ protective of acidic-extractable mycelium polysaccharides by Pleurotus eryngii var. tuoliensis on high-fat emulsion induced-hypertriglyceridemic mice. Sci Rep. 2018;8(1):17500.
-
Kawai G, Babasaki K, Neda H. Taxonomic position of a Chinese Pleurotus "Bai-Ling-Gu": It belongs to Pleurotus eryngii (DC.: Fr.) Quel. and evolved independently in China. Mycoscience. 2008;49:75-87.
-
Yamamoto S, Yamashina K, Ishikawa M, Gotoh M, Yagishita S, Iwasa K, Maruyama K, Murakami-Murofushi K, Yoshikawa K. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease. J Neuroinflammation. 2017;14(1):142.
-
Yamamoto S, Gotoh M, Kawamura Y, Yamashina K, Yagishita S, Awaji T, Tanaka M, Maruyama K, Murakami-Murofushi K, Yoshikawa K. Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice. Eur J Pharmacol. 2014;741:17-24.
-
Yoshikawa K, Palumbo S, Toscano CD, Bosetti F. Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage. Prostaglandins Leukot Essent Fatty Acids. 2011;85(1):43-52.
-
Iwasa K, Yamamoto S, Takahashi M, Suzuki S, Yagishita S, Awaji T, Maruyama K, Yoshikawa K. Prostaglandin F2a FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model. Prostaglandins Leukot Essent Fatty Acids. 2014;91(5):175-82.
-
Hashimoto M, Yamamoto S, Iwasa S, Yamashina K, Ishikawa M, Maruyama K, Bosetti F, Yoshikawa K. The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation. Brain Res Bull. 2017;135:47-52.
-
Wang Z, Baharani A, Wei Z, Truong D, Bi X, Wang F, Li XM, Verge VMK, Zhang Y. Low field magnetic stimulation promotes myelin repair and cognitive recovery in chronic cuprizone mouse model. Clin Exp Pharmacol Physiol. 2021;48(8):1090-102.
-
Fatmawati S, Shimizu K, Kondo R. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum. Fitoterapia. 2010;81(8):1033-6.
-
Usiobeigbe OS, Omoviye EO, Kayode A, Hassan AO, Abdulrahman AO. Effect of some selected plants in the treatment of viral infection. AJSR. 2021;3(1):188-211.
-
Yuan JP, Wang JH, Liu X, Kuang HC, Huang XN. Determination of ergosterol in ganoderma spore lipid from the germinating spores of Ganoderma lucidum by high-performance liquid chromatography. J Agric Food Chem. 2006;54(17):6172-6.
-
Wang Q, Xu M, Zhao L, Wang F, Li Y, Shi G, Ding Z. Transcriptome dynamics and metabolite analysis revealed the candidate genes and regulatory mechanism of ganoderic acid biosynthesis during liquid superficial-static culture of Ganoderma lucidum. Microb Biotechnol. 2021;14(2):600-13.
-
Ohl K, Tenbrock K, Kipp M. Oxidative stress in multiple sclerosis: Central and peripheral mode of action. Exp Neurol. 2016;277:58-67.
-
Praet J, Guglielmetti C, Berneman Z, Van der Linden A, Ponsaerts P. Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis. Neurosci Biobehav Rev. 2014;47:485-505.
-
Sun XZ, Liao Y, Li W, Guo LM. Neuroprotective effects of ganoderma lucidum polysaccharides against oxidative stress-induced neuronal apoptosis. Neural Regen Res. 2017;12(6):953-8.
-
Taofiq O, Heleno SA, Calhelha RC, Alves MJ, Barros L, Gonzalez-Paramas AM, Barreiro MF, Ferreira I. The potential of Ganoderma lucidum extracts as bioactive ingredients in topical formulations, beyond its nutritional benefits. Food Chem Toxicol. 2017;108(Pt A):139-47.
-
Honarvar F, Hojati V, Bakhtiari N, Vaezi G, Javan M. Myelin protection by ursolic acid in cuprizone-induced demyelination in mice. Iran J Pharm Res. 2019;18(4):1978-88.
-
Zhang Y, Li X, Ciric B, Curtis MT, Chen WJ, Rostami A, Zhang GX. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proc Natl Acad Sci U S A. 2020;117(16):9082-93.
-
Yamamoto S, Sakemoto C, Iwasa K, Maruyama K, Shimizu K, Yoshikawa K. Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1. J Pharmacol Sci. 2020;144(3):119-22.
-
Wergeland S, Torkildsen 0, Myhr KM, Aksnes L, Mark SJ, B0 L. Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS One. 2011;6(10):e26262.
-
Nystad AE, Torkildsen 0, Wergeland S. Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model. J Neuroimmunol. 2018;321:61-5.
-
Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: A comprehensive review. Neurol Ther. 2018;7(1):59-85.
-
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-8.
-
Ozzard A, Hear G, Morrison G, Hoskin M. Vitamin D deficiency treated by consuming UVB-irradiated mushrooms. Br J Gen Pract. 2008;58(554):644-5.
-
Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009;132(Pt 5):1146-60.
-
Zhang CC, Yin X, Cao CY, Wei J, Zhang Q, Gao JM. Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells. Bioorg Med Chem Lett. 2015;25(22):5078-82.
-
Acosta CM, Cortes C, MacPhee H, Namaka MP. Exploring the role of nerve growth factor in multiple sclerosis: Implications in myelin repair. CNS Neurol Disord Drug Targets. 2013;12(8):1242-56.
-
Kolotushkina EV, Moldavan MG, Voronin KY, Skibo GG. The influence of Hericium erinaceus extract on myelination process in vitro. Fiziol Zh. 2003;49(1):38-45.
-
Moldavan M, Grygansky AP, Kolotushkina OV, Kirchhoff B, Skibo GG, Pedarzani P. Neurotropic and trophic action of lion's mane mushroom Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetidae) extracts on nerve cells in vitro. Int J Med Mushrooms. 2007;9(1):15-28.
-
Ye JN, Chen XS, Su L, Liu GL, Cai QY, Zhan HL, Xu Y, Zhao SF, Yao GX. Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice. PLoS One. 2013;8(1):e54590.
-
Diamantopoulou P, Papanikolaou S, Kapoti M, Komaitis M, Aggelis G, Philippoussis A. Mushroom polysaccharides and lipids synthesized in liquid agitated and static cultures. Part I: Screening various mushroom species. Appl Biochem Biotech- nol. 2012;167(3):536-51.
-
Saini RK, Rauf A, Khalil AA, Kod E, Keum Y, Anwar S, Alamri A, Rengasamy KRR. Edible mushrooms show significant differences in sterols and fatty acid compositions. S Afr J Bot. 2021;144:344-56.
-
Shinto L, Marracci G, Bumgarner L, Yadav V. The effects of omega-3 fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: Implications for multiple sclerosis. Autoimmune Dis. 2011;2011:134592.
-
Chen S, Zhang H, Pu H, Wang G, Li W, Leak RK, Chen J, Liou AK, Hu X. n-3 PUFA supplementation benefits microglial responses to myelin pathology. Sci Rep. 2014;4:7458.
-
Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017;18(1):19.
-
Bj0rnevik K, Chitnis T, Ascherio A, Munger KL. Polyunsaturated fatty acids and the risk of multiple sclerosis. Mult Scler. 2017;23(14):1830-8.
-
Trepanier MO, Hildebrand KD, Nyamoya SD, Amor S, Bazinet RP, Kipp M. Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue. J Neurochem. 2018;145(6):504-15.
-
McNamara RK, Rider T, Jandacek R, Tso P. Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis. Psychiatry Res. 2014;215(3):560-7.
-
Li S, Shah NP. Effects of various heat treatments on phenolic profiles and antioxidant activities of Pleurotus eryngii extracts. J Food Sci. 2013;78(8):C1122-9.
-
Sajon SR, Sana S, Rana S, Rahman SM, Nishi ZM. Mushrooms: Natural factory of anti-oxidant, anti-inflammatory, analgesic and nutrition. J Pharmacogn Phytochem. 2018;7(1):464-75.
-
Siddiqui S, Kamal A, Khan F, Jamali KS, Saify ZS. Gallic and vanillic acid suppress inflammation and promote myelination in an in vitro mouse model of neurodegeneration. Mol Biol Rep. 2019;46(1):997-1011.
-
Antony JM, van Marle G, Opii W, Butterfield DA, Mallet F, Yong VW, Wallace JL, Deacon RM, Warren K, Power C. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci. 2004;7(10):1088-95.
-
Yildiz O, Can Z, Laghari AQ, Sahin H, Malkof M. Wild edible mushrooms as a natural source of phenolics and antioxidants. J Food Biochem. 2015;39(2):148-54.
-
Vallespir F, Crescenzo L, Rodriguez O, Marra F, Simal S. Intensification of low-temperature drying of mushroom by means of power ultrasound: Effects on drying kinetics and quality parameters. Food Bioprocess Technol. 2019;12:839-51.